August 6, 2026

Helping Patients Navigate Direct-to-Patient Prescription Platforms

For patients living with chronic and rare conditions, consistent access to prescription medicines is not optional. It is critical to manage symptoms, prevent disease progression, and maintain quality of life.…

Read More

August 4, 2026

National Survey Finds Overwhelming Voter Support for Increasing Access to Obesity Medicines

(SACRAMENTO, CA) – The Chronic Care Policy Alliance (CCPA) announced today that a recent national survey showed strong, bipartisan support for increasing access to FDA-approved obesity medicines. Commissioned by CCPA, the Morning Consult survey of 2,001 registered voters nationwide also found that Americans overwhelmingly view obesity as a serious chronic disease,…

Read More

July 9, 2026

CCPA Submits Comments to FDA on Peptide Compounding

CCPA Submits Comments to FDA on Peptide Compounding The Chronic Care Policy Alliance (CCPA) submitted comments to the FDA’s Pharmacy Compounding Advisory Committee regarding nomination of several peptide substances for…

Read More